You are here

cystic fibrosis

Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis

Vertex Receives Positive Opinion from CHMP for Kalydeco in Patients 12 to 24 months wth Cystic Fibrosis

CP Wire

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation

Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation

CP Wire

cystic fibrosis

Flag link:

Synspira's Cystic Fibrosis Treatment Receives Orpan Drug Designation

cystic fibrosis

Flag link:

Vivus, diving into the cystic fibrosis sphere, backs stadium step-climbing fundraiser

Vivus, diving into the cystic fibrosis sphere, backs stadium step-climbing fundraiser

Fierce Pharma

cystic fibrosis

Flag link:

Mylan Strikes $463 Million Deal With Novartis for CF Product Line

Mylan Strikes $463 Million Deal With Novartis for CF Product Line

BioSpace

cystic fibrosis

Flag link:

Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination

Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination

CP Wire

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Completes Enrollment of Two Ph III Studies of Cystic Fibrosis Drug Combination

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex cystic fibrosis drug gets expanded approval for use in infants

Vertex cystic fibrosis drug gets expanded approval for use in infants

Reuters

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly

Vertex’s fight club rule: Block new treatments to cystic fibrosis patients until Orkambi is reimbursed properly

Endpoints

Vertex Pharmaceuticals

cystic fibrosis

tezacaftor/ivacaftor

Flag link:

Boehringer Ingelheim lands option on cystic fibrosis gene therapy

Boehringer Ingelheim lands option on cystic fibrosis gene therapy

Fierce Biotech

Boehringer Ingelheim

cystic fibrosis

Oxford BioMedica

Flag link:

Discovery of unknown lung cell points to new target for cystic fibrosis medicines

Discovery of unknown lung cell points to new target for cystic fibrosis medicines

Stat

cystic fibrosis

drug development

Flag link:

Vertex spars with UK's May over Orkambi pricing

Vertex spars with UK's May over Orkambi pricing

Biopharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Galapagos shares are tumbling following disappointing results from a cystic fibrosis trial.

Galapagos shares are tumbling following disappointing results from a cystic fibrosis trial.

Motley Fool

cystic fibrosis

Vertex Pharmaceuticals

Flag link:

Vertex doubles size of cystic fibrosis drug discovery site

Vertex doubles size of cystic fibrosis drug discovery site

Fierce Biotech

Vertex Pharmaceuticals

drug development

cystic fibrosis

Flag link:

AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient

AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient

CP Wire

Ampliphi Biosciences

cystic fibrosis

Flag link:

FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

FDA relaxes clinical hold on Translate Bio’s cystic fibrosis drug

Fierce Biotech

clinical trials

cystic fibrosis

Flag link:

Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering

Proteostasis Therapeutics' Abrupt Turn-Around on Share Offering

CP Wire

Proteostasis Therapeutics

cystic fibrosis

clinical trials

Flag link:

Vertex cancels plans for CF triple combo testing in France, citing failed Orkambi negotiations

Vertex cancels plans for CF triple combo testing in France, citing failed Orkambi negotiations

Fierce Pharma

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

New approval helps Vertex's 'cleanest growth story in biotech'

New approval helps Vertex's 'cleanest growth story in biotech'

Biopharma Dive

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Vertex Picks 'Impressive' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Forbes

Vertex Pharmaceuticals

cystic fibrosis

Flag link:

Pages